FDA Warns OTC Manufacturer for Differences Between Electronic Records, Labeling

The FDA issued a warning letter to Ami Cosmetics in Soeul, South Korea, saying the over-the-counter drugmaker had contradictory information in its labeling and its electronic listing in the FDA’s National Drug Code directory.
Source: Drug Industry Daily